Abyrx
Abyrx, Inc. is a medical device company based in Irvington, New York, specializing in the development, manufacture, and distribution of therapeutic devices for surgical procedures. Founded in 2013, Abyrx offers a range of products, including resorbable hemostatic bone putties and applicator devices designed to stop bone bleeding and facilitate bone healing. The company's technology platforms not only support the re-approximation of bone surfaces but also enable the targeted delivery of drugs to bone. Abyrx's innovative solutions are utilized across various surgical fields, including orthopedic, cranial, maxillofacial, trauma, cardiothoracic, and spine surgeries, promoting efficient recovery for patients.
1 past transactions
ORTHOCON
Acquisition in 2013
ORTHOCON is a medical therapeutics company focused on developing innovative absorbable products specifically for orthopedic and spine surgeries. The company specializes in creating implantable products that effectively address bone bleeding, which is a common challenge in surgical procedures. Among its offerings is the HEMASORB Absorbable Bone Hemostat Matrix, a ready-to-use, biocompatible, water-resistant, and absorbable putty designed to halt bleeding when applied to damaged or cut bone. ORTHOCON's commitment to enhancing surgical outcomes is reflected in its development and manufacturing processes aimed at providing effective solutions for healthcare professionals in the field of orthopedics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.